31 to 40 of 1,158 Results
JPEG Image - 136.2 KB -
MD5: 38ff2dbcf169524a0ac3ae289a7d7a82
Confocal fluorescence microscopy to determine whether dextran and ZOL colocalize in HGFs. From the same experiment, a representative photomicrograph of an HGF in the absence of Dynasore (A, C, E, and G) and a representative photomicrograph of an HGF in the presence of Dynasore (B... |
JPEG Image - 238.1 KB -
MD5: 1848dacb3313d0438b270a286ed930bd
Confocal fluorescence microscopy of live HGFs exposed to LysoSensor Green DND-189 to measure endosomal acidification. Representative field of HGFs in the absence (A) and presence (B) of 30 microM Dynasore in which the exposure settings were kept constant. 20X objective, scale bar... |
JPEG Image - 111.2 KB -
MD5: a264a0113bfaeea8a79565c42aabc60d
Measurement of the perinuclear localization of ZOL and the positive control for macropinocytosis, dextran, in the absence and presence of 30 microM Dynasore. Violin plots display the HGF perinuclear proportion of intracellular TRITC-dextran (A) and AF647-ZOL (D) fluorescence. Hor... |
JPEG Image - 66.2 KB -
MD5: db50edfaef672c4413910622875fe627
This graph displays the "data not shown" in the Dynasore rescue portion of Results. An optimized dose of imipramine (IMI) of 25 microM for one hour prior to 72 hours of incubation in the presence of zoledronate does not rescue the 50 microM zoledronate (ZOL)-treated HGFs. Error b... |
JPEG Image - 62.9 KB -
MD5: d3c779177990d91baf6a82fa93ff3a1e
This graph shows that optimized doses of phosphonoformic acid (PFA) from 0.25-0.75 mM for either a one-hour pre-treatment (PRE) prior or continual exposure during 72 hours of incubation in the presence of zoledronate do not rescue the 50 microM zoledronate (ZOL)-treated human cal... |
JPEG Image - 61.0 KB -
MD5: 67fae0c673edb167b8ee575b1ea088dc
This graph shows that optimized doses of phosphonoformic acid (PFA) from 0.25-0.75 mM for either a one-hour pre-treatment (PRE) prior or continual exposure during 72 hours of incubation in the presence of zoledronate do not rescue the 50 microM zoledronate (ZOL)-treated RAW264.7,... |
JPEG Image - 177.6 KB -
MD5: 98ec63199d7339b808a3344a0a883871
(A) 1.2% non-denaturing agarose gel electrophoresis of purified total HGF RNA. From left to right: lane 1 – MilleniumTM RNA size marker, lane 2 – 1μg RNA, lane 3 – 2.5μg RNA. 28S rRNA and 18S rRNA band clarity with lack of degradation on the agarose gel suggests purity of the iso... |
JPEG Image - 93.5 KB -
MD5: 89777eb55cf9d192dcf69cd76567e586
Figure 1- Schematic drawing of the implant with the area represented by the “cortical bone” space measured by two valleys (in red) and the “cancellous bone” space measured by three valleys (in green). |
JPEG Image - 259.6 KB -
MD5: c435c441ecb8d863a6ffcf667b7bece5
Figure 2- SEM micro images at 10.000 × magnifications of the surface technological groups after treatment on the titanium implants of groups C (a); MN (b), MNSr (c), and MNSr+ (d). Below is Sr mapping by EDS (i; j). e–h show laser scanning confocal microscopy 3D reconstruction im... |
JPEG Image - 81.7 KB -
MD5: 8d7df3a5a07858c8e06b45f668bf3ca0
Figure 3- Means and standard deviations (SD) of removal torque analysis in N/cm of implants with different surface treatments at 15 and 45 days. |
